GET THE APP

Editorial Note on Parkinson’s Disease | 78601

生物学的システム: オープンアクセス

ISSN - 2329-6577

抽象的な

Editorial Note on Parkinson?s Disease

Alekhya Thirunahari

To control the motor and non-motor symptoms of Parkinson's disease, pharmacologic treatments (levodopa therapy [LVT]; dopamine agonists; MAO-B inhibitors; and COMPT-inhibitors) remain the frontline treatment choices (PD). Treatment with dopaminergic agents, especially agonist therapies (ATs), can, however, cause pernicious behavioural syndromes in some patients, which are classified as Impulse Control Disorders (ICDs) in the DSM-IV.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません